Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
This pilot phase I trial studies the side effects and best way to give personalized peptide
vaccine in patients with pancreatic or colorectal cancer that has spread to other places in
the body and usually cannot be cured or controlled with treatment (advanced). Personalized
peptide vaccine is a vaccine developed from patient's own tumor cells and blood in order to
use as a biological therapy. Biological therapies, such as personalized peptide vaccine may
attack tumor cells and stop them from growing or kill them.